Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2453

1.

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

Turner BC, Knisely JP, Kacinski BM, Haffty BG, Gumbs AA, Roberts KB, Frank AH, Peschel RE, Rutherford TJ, Edraki B, Kohorn EI, Chambers SK, Schwartz PE, Wilson LD.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):77-84.

PMID:
9422561
2.

Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.

Sood BM, Jones J, Gupta S, Khabele D, Guha C, Runowicz C, Goldberg G, Fields A, Anderson P, Vikram B.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):208-16.

PMID:
12909235
3.

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.

Kelly MG, O'malley DM, Hui P, McAlpine J, Yu H, Rutherford TJ, Azodi M, Schwartz PE.

Gynecol Oncol. 2005 Sep;98(3):353-9.

PMID:
16005947
4.

Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.

Mundt AJ, Murphy KT, Rotmensch J, Waggoner SE, Yamada SD, Connell PP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1154-60.

PMID:
11483324
5.

Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.

Thomas MB, Mariani A, Cliby WA, Keeney GA, Podratz KC, Dowdy SC.

Gynecol Oncol. 2007 Nov;107(2):186-9. Epub 2007 Aug 3.

PMID:
17688926
6.

Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.

Mehta N, Yamada SD, Rotmensch J, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1004-9.

PMID:
14575831
7.

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.

Murphy KT, Rotmensch J, Yamada SD, Mundt AJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1272-6. Review.

PMID:
12654437
8.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
9.

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.

Grice J, Ek M, Greer B, Koh WJ, Muntz HG, Cain J, Tamimi H, Stelzer K, Figge D, Goff BA.

Gynecol Oncol. 1998 Apr;69(1):69-73.

PMID:
9571001
10.

Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.

Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE.

Gynecol Oncol. 2004 Dec;95(3):469-73.

PMID:
15581948
11.

Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.

Low JS, Wong EH, Tan HS, Yap SP, Chua EJ, Sethi VK, Soh LT, Low J, Tay EH, Chew SH.

Gynecol Oncol. 2005 Apr;97(1):171-7.

PMID:
15790454
12.

Uterine papillary serous carcinoma: patterns of failure and survival.

Wang W, DO V, Hogg R, Wain G, Brand A, Bull C, Stenlake A, Gebski V.

Aust N Z J Obstet Gynaecol. 2009 Aug;49(4):419-25. doi: 10.1111/j.1479-828X.2009.01016.x.

PMID:
19694700
13.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85.

PMID:
12182977
14.

Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.

Stewart KD, Martinez AA, Weiner S, Podratz K, Stromberg JS, Schray M, Mitchell C, Sherman A, Chen P, Brabbins DA.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):527-35.

PMID:
12243832
15.

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma.

Horowitz NS, Peters WA 3rd, Smith MR, Drescher CW, Atwood M, Mate TP.

Obstet Gynecol. 2002 Feb;99(2):235-40.

PMID:
11814503
16.

Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy.

Huh WK, Powell M, Leath CA 3rd, Straughn JM Jr, Cohn DE, Gold MA, Falkner CA, Carey DE, Herzog T, Fowler JM, Partridge EE, Kilgore LC, Alvarez RD.

Gynecol Oncol. 2003 Dec;91(3):470-5.

PMID:
14675664
17.

Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.

Touboul E, Belkacémi Y, Buffat L, Deniaud-Alexandre E, Lefranc JP, Lhuillier P, Uzan S, Jannet D, Uzan M, Antoine M, Huart J, Ganansia V, Milliez J, Blondon J, Housset M, Schlienger M.

Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):81-97.

PMID:
11316550
18.

Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).

Fields AL, Einstein MH, Novetsky AP, Gebb J, Goldberg GL.

Gynecol Oncol. 2008 Jan;108(1):201-6. Epub 2007 Nov 8.

PMID:
17997145
19.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330
20.

Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.

Alektiar KM, McKee A, Venkatraman E, McKee B, Zelefsky MJ, Mychalczak BR, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):707-13.

PMID:
12062616

Supplemental Content

Support Center